Laboratory monitoring of biological therapies in rheumatology: the role of immunogenicity
Ann Lab Med. 2020; 40: 101-113
Autore: Minisola Giovanni
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today
Clin Exp Rheumatol. 2017; 35: 752-765
Co-autore: Giovanni Minisola
The challenge of the definition of early symptomatic knee osteoarthritis: a proposal of criteria and red flags from an international initiative promoted by the Italian Society for Rheumatology
Rheumatol Int. 2017; 37: 1227-1236
Co-autore: Giovanni Minisola
The importance of an early diagnosis in systemic lupus erythematosus
Isr Med Assoc J. 2016; 18: 212-5
Co-autore: Giovanni Minisola
How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study
Aging Clin Exp Res. 2016; 28: 459-68
Co-autore: Giovanni Minisola
Development and first validation of a disease activity score for gout
Arthritis Care Res (Hoboken). 2016; 68: 1530-7
Co-autore: Giovanni Minisola
Lifestyle and dietary habits of patients with gout followed in rheumatology settings
Reumatismo. 2015; 67: 138-48
Co-autore: Giovanni Minisola
Rheumatic diseases and work ability
G Ital Med Lav Ergon. 2014; 36: 276-81
>Autore: Giovanni Minisola
miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis
Hum Immunol. 2010; 71: 206-211
Co-autore: Giovanni Minisola
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study)
Rheumatology (Oxford). 2010; 49: 289-94
Co-autore: Giovanni Minisola
Rimodellamento strutturale dell’osso: approfondimento dei meccanismi molecolari
Osteoporosi.it 2009; 4: 13-6
Autore: Minisola Giovanni
